Cell based therapeutics is one of the most rapidly advancing medical fields, bringing together a range of fields including transplantation, tissue engineering and regeneration, biomaterials and stem cell biology. However, traditional cell-based therapeutics have many limitations, one of which is their harmful effects exhibited on healthy body cells due to their lack of specificity. Nanomedicine is providing an alternative treatment strategy that is more targeted and specific to a range of diseases. Varying from polymers conjugated with drugs or tissue targeting molecules, to proteins encapsulated within a polymer shell, nanomedicine will without a doubt play a major role in designing effective cell-based therapeutics that can overcome certain classical problems. These may include from addressing the problem of non-specificity of contemporary treatments to overcoming mechanical barriers, such as crossing cell membranes. This review summarises the recent work on nano-based cell therapy as a regenerative agent and as a therapeutic for cancer and neurological diseases.
PEGylation of nanoparticles allows them to escape the reticulo-endothelial system, which is a significant biological barrier (8) . Poly(lactide-co-glycolide) (PLGA) nanoparticles are being studied as a potential drug delivery system, and have shown very promising results.
PLGA shows no cytotoxicity, as it undergoes hydrolysis in the body, forming biocompatible fragments which are then metabolized and removed from the body through the citric acid cycle (9).
PLGA nanoparticles are also able to cross the Blood Brain Barrier, and so show promise in treating neurological and psychiatric disorders, as well as other diseases (9) . Nanocrystals are crystalline form of a drug, formed from aggregation of the drug molecules, surrounded by a thin coat of a surfactant (10) . The nature of the coating on the nanocrystals determines the biological reaction, but a hydrophilic coating increases bioavailability and biodistribution, and prevents the crystals aggregating (10) . Therefore, high doses of a drug can be achieved using nanocrystals, and by coating with nanomaterials poorly soluble drugs can have a higher bioavailability (10). 
Nanotechnology and Regenerative Medicine
Regenerative medicine focuses on restoring Table 1 shows the various anti-cancer drugs and the nanoformulations used to target different cancers.
Cancer Stem Cells
Another landmark on the road to curing cancer has been the discovery of cancer stem cells The effect of increasing the dose for CSCs will also increase the dose for the rest of the body, making it dangerous. Therefore, increased exposure needs improved specificity, either by using nanoparticles, or by overcoming transport resistance mechanisms (3) . One of the main Liposomes can also be coupled with mannose, transferrin or insulin receptors to cross the BBB.
The transferrin receptor in particular is more highly expressed in the BBB during certain pathologies, in this case after a stroke. It has been shown in a rat model that transferrin-conjugated liposomes could specifically target the post-ischemic brain endothelium after a stroke (32) .
Nanoparticles coated with a PEG-containing surfactant have been used to deliver a range of drugs to the CNS, including analgesics, anticonvulsants and anti-cancer agents (31) ( Table 2 ). A healthy blood brain barrier has intact tight junctions to prevent unmediated passage of molecules into the brain, whereas a diseased blood brain barrier can have defective tight junctions, becoming 'leaky', and allowing molecules, unrestricted entry into the brain endothelium. Neurodegenerative disorders are also becoming more prominent in today's aging society, and so there is much research being undertaken to develop methods of getting drugs across the BBB into neural tissue to treat these disorders.
Nanomedicine is thus developing into a seemingly limitless field to detect, diagnose and treat a huge range of diseases and disorders.
